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Purpose or Objective: Version9.10 of Pinnacle3 TPS 
(PhilipsMedical Systems) includes Auto-Planning (AP) module. 
The user definesbeams, optimization goals for PTV-coverage 
and threshold doses for each organat risk (OARs). TheAP 
engine tries to meet the goals and further lower dose to OARs 
with minimalcompromise to the target coverage by multiple 
optimization iterative loops andby automatically creation of 
objectives and optimization on additionalstructures. The aim 
of this study was to evaluate and compare APplans with 
different TPS manual ones for liver stereotactic body 
radiotherapy(SBRT) treatments. 
 
Material and Methods: Ten patients with liver tumour were 
included in thestudy. Six plans were created for each 
patient. Two plans were generated withAP of Pinnacle3 TPS 
(version 9.10) using SmartArc technique and two 
withtraditional planning (MP), always with Pinnacle 
SmartArc, by two differentexpert medical physicists. Others 
two experts performed two VMAT plans withMonaco TPS 
(version 5.0, Elekta) (VM). Dosimetry comparison was done in 
termsof the PTV coverage, gEUD, OARs (normal liver, 
kidneys, spinal cord, bowel,heart, rib cage, stomach and 
major vessels) sparing, as well as homogeneityindex (HI), 
conformity index (CI) and gradient index (GI). Also total 
monitorunits, number of beam segments and beams 
complexity metrics (plan average beamarea BA, plan average 
beam irregularity PI and plan average beam modulation 
PM)were evaluated.  
 
Results: Preliminary results of three patients indicatedthat, 
for same gEUD (p value = 0.99), there were not significant 
differences betweenAP, MP and VM for CI (p = 0.83). Relevant 
differences were found instead aboutbeams complexity 
metrics (p = 0.23 for BA, 0.01 for PI and 0.05 for PM), HI (p= 
0.03), monitor units and OAR sparing. In particular, median 
and mean values ofmonitor units were respectively 3212 and 
3646 ± 1529 for AP, 2930 and 2923 ± 447 for MP and 5006 and 
4850 ±570 for VM. Similar data were found for number of 
beams segments. Also forOARs, in particular for healthy liver, 
results showed different behaviour ofTPS. The healthy liver 
median volume below 15 Gy was 592 cc for AP, 596 cc forMP 
and 659 cc for VM; the mean values were 625 ± 150 cc for AP, 
632 ± 120 ccfor MP and 673 ± 46 cc for VM. 
 
 
 
Conclusion: Analysis of first three patientsdemonstrated that 
AP and MP employed much less monitor units respect to VM 
andshowed a minor PI. However, in particular complex cases, 
AP and MP had moredifficulty to spare the organs at risk than 
VM. Furthermore, there was sensibleintra-patients variability 
for AP and MP. AP was less human employment time 
consumingthan both manual planning systems. At the 
congress, results of all ten patientswill be presented. 
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Purpose or Objective: RapidPlan (RP) knowledge-based 
treatment planning software has been in clinical use at our 
institution since November 2014 and, to date, has been used 
to plan in excess of 100 patients. Models have been created 
for a variety of treatment sites, and plans have been 
compared with class-solution based methods of optimising in 
terms of plan quality and efficiency of planning and delivery. 
 
Material and Methods: A prostate model was generated 
based on 5-field IMRT plans with three prescribed dose levels 
(78Gy/71Gy/60Gy, delivered in 37 fractions). Prior to routine 
clinical use of the model, planning and delivery efficiency 
were investigated using twenty patients, who were planned 
first using local objective templates, and then reoptimised 
using RP-generated objectives. Six planners of varying 
experience participated, and the same planner performed 
both optimisations for a patient. The planners timed how 
long each method took to generate a plan, and also noted 
how the RP plan compared with the standard plan, and 
whether further modifications were required after the initial 
RP optimisation.  
Following final adjustments to the model, it was put into 
routine clinical use for all prostate cases with three dose-
levels. Further models were created for cervix patients 
treated with RapidArc and post-prostatectomy patients; both 
single dose-level. For all models, a record was kept of 
situations where RapidPlan was unable to generate an 
acceptable distribution to allow further investigation and 
modification of model parameters as required. Additionally, 
the applicability of the models to situations outside the 
original scope was investigated. 
 
Results: The results of the double-planning study can be seen 
in Table 1 & Fig. 1. RapidPlan produced a plan that was of 
equal or higher quality in 85% of cases, and the planning 
times were significantly reduced with a median time saving 
of 70 mins per patient (range 0-240min). The spread on the 
timings was much smaller for RP, indicating that the planning 
times were less dependent on case complexity and planner 
experience when using RapidPlan. Monitor units were found 
to be slightly higher with RP (p=0.03); however, this is 
unlikely to be clinically significant. 
Considerable reductions in planning time were also seen for 
the cervix and post-prostatectomy models. Continuing 
evaluation of all models in routine use has indicated that 
they work well for the majority of the population. The 
models were also found to give a good starting point for 
situations outside the initial scope in some instances, e.g. the 
cervix model was used successfully for both a single dose-
level prostate + nodes and a two dose-level endometrium + 
para-aortic nodes. 
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Conclusion: RapidPlan has been found to produce good 
quality plans more efficiently than class-solution based 
methods in the majority of cases. Continual monitoring of 
model behaviour is recommended to allow refinement in 
order to ensure optimum performance for all patients. 
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Purpose or Objective: The inverse planning for IMRT is 
variable due to a high number of parameters to be defined by 
the operator. So the quality of treatment plan depends on 
the level of operator expertise. The aim of this study was to 
evaluate the automatic “AutoPlanning” planning tool 
implemented in Pinnacle v9.10 TPS (Philips) for IMRT 
Step&Shoot (S&S) and VMAT techniques for three 
localisations: prostate, pelvis and head and neck (H&N) with 
integrated boost technique with three dose level. 
 
Material and Methods: Twelve patient cases, four by 
localisation, were planned both for S&S and VMAT. The 
AutoPlanning method (AP) was compared with those obtained 
with a conventional manual planning method. The plan 
quality evaluation was based on the dose distributions (HDV 
and isodose), the dose homogeneity (HI), dose conformity 
(Conformal Number (NC) and COnformal INdex (COIN)) and 
complexity indexes (Plan Area (PA)) and Monitor Units (MU) 
number. The agreement between planned and measured 
doses was evaluated with Gamma index test with criteria of 
3% and 3mm; the mean gamma value and the percentage of 
accepted points were also compared. The dosimetric QA was 
performed by Octavius 4D device (PTW). 
 
Results: HDV AP plans showed equivalent quality compared 
to the manual plan. With AP for pelvis case, the median dose 
for bladder decreased by 6% and 4% for S&S and VMAT 
techniques respectively. With AP for H&N case, the parotids 
were better saving: the dose received by 30% of the volume 
decreased by 12% and 14% for S&S and VMAT techniques 
respectively; this sometimes causes a deteriorate of 
intermediate risk PTV coverage (PTV 63 Gy). The 
homogeneity index showed a lower interpatient variation for 
plan with AP: the standard deviation was 0.006 for S&S with 
AP against 0.030 for S&S with manual method. In case of 
prostate and pelvis, plans computed from the automated 
method showed greater conformity than those issued by the 
manual method but not in case of H&N. With regard to 
complexity of plan, the decrease in the area of the 
irradiation field (- 9.2 cm² on average) and the increase of 
the MU number (+ 104.5 MU on average) showed worse 
efficiency of automated plans than manual plans. The 
agreement between planned and measured doses was similar 
between the two planning methods. 
 
 
 
Table 1: Comparison of dose values, dosimetric and 
efficiency indexes for the prostate, pelvis and head&neck 
cases calculated with a conventional planning method (S&S 
and VMAT) and with AutoPlanning method (S&S AP and VMAT 
AP). The bold and underlined values are those most 
favorable. 
 
Conclusion: We validated the feasibility of the automated 
planning AutoPlanning method in S&S and VMAT in three 
localisations. However, intake of AutoPlanning can be 
considered variable according to the center experience. The 
manual actions are limited with Autoplanning because the 
operator does not restart the optimization once the process 
is finish, unlike the manual planning, where the operator re 
optimizes the plan sometimes several times according to his 
own expertise. 
 
EP-1643  
Rapidplan: 'knowledge-based' model with Tomotherapy 
plans 
A. Botti
1Arcispedale S. Maria Nuova, Medical Physics, Reggio Emilia, 
Italy 
1, E. Cagni1, R. Micera2, S. Nicola2, L. Orsingher1, M. 
Orlandi1, C. Iotti2, L. Cozzi3, M. Iori1 
2Arcispedale S. Maria Nuova, Radiotherapy, Reggio Emilia, 
Italy 
3Istituto Clinico Humanitas, Radiotherapy and Radiosurgery, 
Milan, Italy 
 
Purpose or Objective: In the radiotherapy planning process 
the expertise and experience of the operator is essential. 
This represents a critical element which can limit the quality 
of a therapy especially when using advanced technologies 
such as volumetric modulated arc therapy (VMAT). The 
automation of 'knowledge-based' planning procedures stands 
as a possible solution to improve the consistency of the plans. 
RapidPlan (RP) (Varian Medical Systems, USA), uses libraries 
of plans to create models that, basing on the delivery 
technique and patient's anatomy, predicts the dose-volume 
histograms of the organs at risk (OAR) and propose 
optimization constraints, avoiding long and multiple 
interactive optimization processes for new patients. In this 
scenario, it is useful to understand whether knowledge-based 
models, created using plans with consolidated technique, 
could supply the lack of the planning experience for a new 
treatment technique. In this study, HT (Hi-Art, Accuray, USA) 
plans of prostate cancer patients were used to create two RP 
models suitable for RapidArc (RA) plans. The aim of the work 
was to evaluate the feasibility and the performance of these 
models. 
 
Material and Methods: In order to create the RP models, 2 
groups of HT plans for prostate cancer patients, that included 
sparing of the rectum, bladder, and femoral heads, were 
selected: low risk group (LR), consisting of 35 plans, aimed to 
deliver 70 Gy to prostate PTV (PTVp) in 28 fractions – 
intermediate risk group (IR) consisting of 30 simultaneous 
integrated boost (SIB) plans with a prescribed dose of 70 Gy 
to PTVp and 56 Gy to vesicles PTV (PTVv) in 28 fractions. In 
order to prevent outliers, for all selected plans, structures 
and dose distributions were verified and validated by a 
radiation oncologist. The dose distributions of each plan were 
